⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRKR News
Marker Therapeutics, Inc. Common Stock
Pancreatic Cancer - Drug Pipeline Insight, 2026 | 170+ Companies and 200+ Therapies Signal Licensing, Investment, and Immuno-Oncology Growth Opportunities
globenewswire.com
MRKR
VRTX
ABUS
AGEN
IMUX
CANF
Form 8-K
sec.gov
MRKR
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
globenewswire.com
MRKR
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
globenewswire.com
MRKR
Merakris Therapeutics Launches Patent-Pending AmnioSurge™ With 360 Medical, Opening New Surgical Revenue Channel
globenewswire.com
MRKR
Meijer lanza una nueva marca de ropa de trabajo asequible en los hipermercados de todo el Medio Oeste USA - español USA - English
prnewswire.com
MRKR
OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer
prnewswire.com
MRKR
Form 8-K
sec.gov
MRKR
Merakris Therapeutics and iFyber Collaboration Receives Top SAWC Research Award for MTX-001 Wound Healing Study in Human Skin Model
globenewswire.com
MRKR
Merakris Therapeutics Provides FDA Update and Reports Interim Findings for MTX-001 in Venous Leg Ulcers
globenewswire.com
MRKR